NBMBX
Price
$19.10
Change
-$0.06 (-0.31%)
Updated
Nov 13 closing price
RPTIX
Price
$112.99
Change
-$0.33 (-0.29%)
Updated
Nov 13 closing price
Ad is loading...

NBMBX vs RPTIX

Header iconNBMBX vs RPTIX Comparison
Open Charts NBMBX vs RPTIXBanner chart's image
Neuberger Berman Mid Cap Growth Adv
Price$19.10
Change-$0.06 (-0.31%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$112.99
Change-$0.33 (-0.29%)
VolumeN/A
CapitalizationN/A
NBMBX vs RPTIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NBMBX vs. RPTIX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBMBX is a StrongBuy and RPTIX is a Buy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 32B vs. NBMBX (1.93B). RPTIX pays higher dividends than NBMBX: RPTIX (0.18) vs NBMBX (0.00). NBMBX was incepted earlier than RPTIX: NBMBX (28 years) vs RPTIX (9 years). NBMBX is a more actively managed with annual turnover of: 101.00 vs. RPTIX (21.70). NBMBX has a lower initial minimum investment than RPTIX: NBMBX (0) vs RPTIX (500000). NBMBX annual gain was more profitable for investors over the last year : 38.84 vs. RPTIX (21.29). NBMBX (18.85) and RPTIX (18.66) have equivalent 5 years return.
NBMBXRPTIXNBMBX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years9 years-
Gain YTD29.45913.037226%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.93B32B6%
Annual Yield % from dividends0.000.18-
Returns for 1 year38.8421.29182%
Returns for 3 years-19.80-14.64135%
Returns for 5 years18.8518.66101%
Returns for 10 years36.91N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNMD74.77-0.09
-0.12%
CONMED Corp
DOX92.71-0.15
-0.16%
Amdocs Limited
TERN7.17-0.29
-3.89%
Terns Pharmaceuticals
AUUD0.57-0.06
-8.93%
Auddia
EBS10.89-1.08
-9.02%
Emergent Biosolutions